European Society for Vascular Surgery European Society for Vascular Surgery

In this episode Abena A and Leana Dogbe (@leanadogbe) partner with Vaiva Dabravolskaite (vaivadabravolskaite@gmail.com) from ESVS to host an episode discussing social deprivation in vascular surgery. Dr. Tara Mastracci and Dr. Olamide Alabi join us to offer insights into how social deprivation drives disparities in outcomes and steps on how we can shift practice paradigms to better address our patient needs.

Dr. Tara Mastracci (@aorticsurgeon) is a vascular surgeon with over 15 years of experience treating and managing complex aortic pathologies. She is currently working at St. Bartholomew’s Hospital in London, UK, on the Cardiothoracic Team doing complex aortic surgery. On top of her clinical duties, Dr. Mastracci is dedicated to studying the social and non-clinical factors influencing vascular outcomes.

Dr. Olamide Alabi (@OAlabiMD) is an Associate Professor of Surgery in the Department of Surgery at Emory University School of Medicine. Her clinical effort focuses on the full scope of vascular disease for patients at Emory University Hospital and the Atlanta VA HealthCare System, however, her academic portfolio and funded research is focused primarily on the intersection of peripheral artery disease, quality, and health equity.

References:
● Social Deprivation and the Association With Survival Following Fenestrated Endovascular Aneurysm Repair/2021 https://www.annalsofvascularsurgery.com/article/S0890-5096(21)00872-4/fulltext
● Is social deprivation an independent predictor of outcomes following cardiac surgery? An analysis of 240,221 patients from a national registry. BMJ/2015 https://bmjopen.bmj.com/content/5/6/e008287.long
● Survival Disparity Following Abdominal Aortic Aneurysm Repair Highlights Inequality in Ethnic and Socio-economic Status/ https://www.ejves.com/article/S1078-5884(17)30521-X/fulltext
● Nash, D., McClure, G., Mastracci, T. M., & Anand, S. S. (2022). Social deprivation and peripheral artery disease. Canadian Journal of Cardiology, 38(5), 612-622.
● Vart, P., Coresh, J., Kwak, L., Ballew, S. H., Heiss, G., & Matsushita, K. (2017). Socioeconomic status and incidence of hospitalization with lower‐extremity peripheral artery disease: atherosclerosis risk in communities study. Journal of the American Heart Association, 6(8), e004995.
● Henry, A. J., Hevelone, N. D., Belkin, M., & Nguyen, L. L. (2011). Socioeconomic and hospital-related predictors of amputation for critical limb ischemia. Journal of vascular surgery, 53(2), 330-339.
● Demsas, F., Joiner, M. M., Telma, K., Flores, A. M., Teklu, S., & Ross, E. G. (2022, June). Disparities in peripheral artery disease care: A review and call for action. In Seminars in vascular surgery (Vol. 35, No. 2, pp. 141-154). WB Saunders.

The authors of the Virtual Vascular chapter on "Aortic graft infection and mycotic (infected) aortic aneurysms", Anders Wanhainen, Hamid Gavali, and Ivika Heinola, join us on this week's podcast to talk about mycotic aneurysms.
Virtual Vascular is an online living textbook, with chapters on various topics in vascular surgery, written by experts around the globe. It is accessible via the ESVS Library, open to all ESVS Members.

In this podcast we talk with Dr. David Lewis, head of the ESVS Academy’s Professional Development and Academic pathway, about the importance of non-technical skills for surgeons, aspects of vascular surgical training that are often overlooked on training programs, what workshops this pathway includes, and who they are addressed to, among other details. You will definitely find it interesting and useful.

This is the third and last podcast of the Q&A series on the ESVS 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases. In this last edition, we talk with Prof. Chris Twine and Stavros Kakkos about some recommendations and their underlying evidence regarding antithrombotic treatment in venous thromboembolic disease and vascular access for haemodialysis. It has been a pleasure learning from these world experts. More Q&A series on new ESVS clinical practice guidelines coming up soon. Keep tuned!

Here comes the second podcast of the Q&A series on the ESVS 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases. This time we address, with Prof. Chris Twine, evidence and recommendations for antithrombotic treatment in lower limb ischemic disease. A must!

Here is the first of a series of Q&A podcasts on ESVS clinical practice guidelines. We start with the ESVS 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases, and, in this first release, Prof. Chris Twine clarifies the evidence underlying some recommendations on antithrombotic therapy in carotid artery disease. Key for our everyday clinical practice, don't miss it!